Emily Armitage
Emily Armitage
Shimadzu Corporation
No hay ninguna dirección de correo electrónico verificada.
Citado por
Citado por
Metabolomics in cancer biomarker discovery: current trends and future perspectives
EG Armitage, C Barbas
Journal of pharmaceutical and biomedical analysis 87, 1-11, 2014
Influence of missing values substitutes on multivariate analysis of metabolomics data
PS Gromski, Y Xu, HL Kotze, E Correa, DI Ellis, EG Armitage, ML Turner, ...
Metabolites 4 (2), 433-452, 2014
Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample
J Godzien, V Alonso-Herranz, C Barbas, EG Armitage
Metabolomics 11, 518-528, 2015
Missing value imputation strategies for metabolomics data
EG Armitage, J Godzien, V Alonso‐Herranz, Á López‐Gonzálvez, ...
Electrophoresis 36 (24), 3050-3060, 2015
Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography–mass spectrometry and capillary electrophoresis–mass spectrometry metabolomics approach
JV Alberice, AFS Amaral, EG Armitage, JA Lorente, F Algaba, E Carrilho, ...
Journal of Chromatography A 1318, 163-170, 2013
Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics
EG Armitage, AD Southam
Metabolomics 12, 1-15, 2016
Applications of metabolomics in cancer studies
EG Armitage, M Ciborowski
Metabolomics: From fundamentals to clinical applications, 209-234, 2017
Metabolomics as a tool for drug discovery and personalised medicine. A review
A Mastrangelo, E G Armitage, A García, C Barbas
Current topics in medicinal chemistry 14 (23), 2627-2636, 2014
A novel untargeted metabolomics correlation-based network analysis incorporating human metabolic reconstructions
HL Kotze, EG Armitage, KJ Sharkey, JW Allwood, WB Dunn, KJ Williams, ...
BMC systems biology 7, 1-11, 2013
Looking into aqueous humor through metabolomics spectacles− exploring its metabolic characteristics in relation to myopia
C Barbas-Bernardos, EG Armitage, A García, S Mérida, A Navea, ...
Journal of pharmaceutical and biomedical analysis 127, 18-25, 2016
Complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine
EG Armitage, AQI Alqaisi, J Godzien, I Peña, AJ Mbekeani, ...
Antimicrobial Agents and Chemotherapy 62 (5), 10.1128/aac. 02095-17, 2018
Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells
EG Armitage, HL Kotze, JW Allwood, WB Dunn, R Goodacre, KJ Williams
Scientific Reports 5 (1), 15649, 2015
In‐source fragmentation and correlation analysis as tools for metabolite identification exemplified with CE‐TOF untargeted metabolomics
J Godzien, EG Armitage, S Angulo, MP Martinez‐Alcazar, ...
Electrophoresis 36 (18), 2188-2195, 2015
A single in-vial dual extraction strategy for the simultaneous lipidomics and proteomics analysis of HDL and LDL fractions
J Godzien, M Ciborowski, EG Armitage, I Jorge, E Camafeita, E Burillo, ...
Journal of proteome research 15 (6), 1762-1775, 2016
Evaluating the challenges associated with time-of-fight secondary ion mass spectrometry for metabolomics using pure and mixed metabolites
JS Fletcher, HL Kotze, EG Armitage, NP Lockyer, JC Vickerman
Metabolomics 9, 535-544, 2013
ToF‐SIMS as a tool for metabolic profiling small biomolecules in cancer systems
HL Kotze, EG Armitage, JS Fletcher, A Henderson, KJ Williams, ...
Surface and Interface Analysis 45 (1), 277-281, 2013
Differentiating signals to make biological sense–A guide through databases for MS‐based non‐targeted metabolomics
A Gil de la Fuente, E Grace Armitage, A Otero, C Barbas, J Godzien
Electrophoresis 38 (18), 2242-2256, 2017
To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients
J Piszcz, EG Armitage, A Ferrarini, FJ Rupérez, A Kulczynska, L Bolkun, ...
Oncotarget 7 (16), 22324, 2016
Metabolomics of diet-related diseases using mass spectrometry
EG Armitage, FJ Rupérez, C Barbas
TrAC Trends in Analytical Chemistry 52, 61-73, 2013
Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer
A Navarrete, EG Armitage, M Musteanu, A García, A Mastrangelo, R Bujak, ...
Pharmacology research & perspectives 2 (6), e00067, 2014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20